Erika Folestad

1.3k citations
16 papers · 927 indexed · h-index 12
Topics
Cancer, Hypoxia, and Metabolism (2 papers)Liver Disease Diagnosis and Treatment (2 papers)Lipid metabolism and biosynthesis (2 papers)

In The Last Decade

Erika Folestad

16 papers receiving 922 citations

Peers

Erika Folestad
Comparison fields: 5 of 81
  • Molecular Biology 353
  • Epidemiology 196
  • Pulmonary and Respiratory Medicine 152
  • Cancer Research 151
  • Neurology 147
Replace Chun-Man Yuen with:
Chun-Man Yuen Taiwan
Leorah Ross United States
Enming J. Su United States
Laurel S. Kleppe United States
Fengyan Jin China
Sulpicio G. Soriano United States
Wei Bai China
Shinichiro Yamada Japan
Yeon Hee Cho South Korea
Erika Folestad relative to Chun-Man Yuen Taiwan Chun-Man Yuen's profile →
Citations per field
00.5×1.5×1.8×
Chun-Man Yuen · 1×
Citations per year

Countries citing papers authored by Erika Folestad

Since Specialization
Citations

This map shows the geographic impact of Erika Folestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erika Folestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erika Folestad more than expected).

Fields of papers citing papers by Erika Folestad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erika Folestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erika Folestad. The network helps show where Erika Folestad may publish in the future.

Co-authorship network of co-authors of Erika Folestad

This figure shows the co-authorship network connecting the top 25 collaborators of Erika Folestad. A scholar is included among the top collaborators of Erika Folestad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erika Folestad. Erika Folestad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 1
2 2
3 33
4 82
5 3
6 46
7 21
8 9
9 42
10 33
11 36
12 39
13 40
14 73
15 359
16 108

About Erika Folestad

Erika Folestad is a scholar working on Biochemistry, Cancer Research and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 927 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Lipid metabolism and biosynthesis (2 papers). The work is most often cited by research in Neurology (147 citations), Cancer Research (151 citations) and Hematology (98 citations). Erika Folestad has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include Ulf Eriksson, Kristian Pietras, Christer Betsholtz, Daniel A. Lawrence, Enming J. Su, Kris Mann, Dick Wågsäter, Linda Fredriksson, Annica Pontén and Anne Kunath. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026